At the IGTP TODAY

News

A community-based action led by IGTP facilitates screening and access to treatment for viral hepatitis among migrant populations in Catalonia

On the occasion of World Hepatitis Day, IGTP presents the results of the HepBClink project, which has combined community educational actions on hepatitis B and C with screening and referral to treatment for migrants from Pakistan, Senegal and Romania. The project has involved the participation of the DxEpiPath group at IGTP and is part of the Tranversal Program CORE.

A new European study with the participation of GCAT reveals that the combination of urban environmental factors increases asthma risk

Researchers from GCAT have taken part in a study on the effects of various environmental factors on the risk of developing asthma over the course of life. The study involved nearly 350,000 participants from European cohorts and used geolocation technologies and satellite imagery to estimate exposure to different environmental elements. The results show a clear link between urban conditions and an increased risk of asthma.

DM1-Hub launches as a national multi-centre study to transform research and care for Myotonic Dystrophy type 1

On 2 June, IGTP hosted the kick-off event for the DM1-Hub, a multicentre project driven by the the group GRENBA, which aims to create a comprehensive national registry of patients with Myotonic Dystrophy type 1 (DM1). The event brought together researchers, clinical professionals, institutional representatives and patient associations from across Spain.

FOXP4 gene identified in the first large-scale genetic study on Long COVID with participation of the GCAT

New insights into the complexities of Long COVID have been brought to light, thanks to an international collaborative effort with the participation of researchers from GCAT|Genomes for life, a strategic project of IGTP. A study published today in Nature Genetics used the vast data from the COVID-19 Host Genetics Initiative to perform the first study examining the entire genetic code specifically focused on Long COVID.